Melanocytic nevus epidemiology and demographics

Melanocytic nevus Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Melanocytic Nevus from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Melanocytic nevus epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Melanocytic nevus epidemiology and demographics All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Melanocytic nevus epidemiology and demographics
CDC on Melanocytic nevus epidemiology and demographics
Melanocytic nevus epidemiology and demographics in the news
Blogs on Melanocytic nevus epidemiology and demographics
Directions to Hospitals Treating Melanocytic nevus
Risk calculators and risk factors for Melanocytic nevus epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]

Overview

Darker skin shades tend to have fewer moles compared to fair complexion.

Epidemiology and demographics

Darker skin shades, however, tend to have fewer moles. According to the American Academy of Dermatology, the majority of moles appear during the first two decades of a person’s life while about one in every 100 babies are born with moles. Some folklore about moles includes the notion that picking at a mole can cause it to become cancerous or grow back larger.